Swiss National Bank Spectrum Pharmaceuticals Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$1.27 - $2.42 $453,263 - $863,698	-356,900 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$2.15 - $3.82 $38,700 - $68,760	18,000 Added 5.31%	356,900 $778,000
Q2 2021 Aug 06, 2021	BUY	$2.89 - $4.45 $27,166 - $41,830	9,400 Added 2.85%	338,900 $1.27 Million
Q4 2020 Feb 05, 2021	BUY	$3.38 - $5.14 $55,432 - $84,296	16,400 Added 5.24%	329,500 $1.12 Million
Q3 2020 Nov 09, 2020	BUY	$2.99 - $4.9 $179,998 - $294,980	60,200 Added 23.8%	313,100 $1.28 Million
Q2 2020 Aug 05, 2020	BUY	$2.11 - $3.38 $123,435 - $197,730	58,500 Added 30.09%	252,900 $855,000
Q4 2019 Feb 06, 2020	BUY	$3.5 - $10.35 $18,550 - $54,855	5,300 Added 2.8%	194,400 $708,000
Q3 2019 Nov 12, 2019	BUY	$7.03 - $9.7 $21,793 - $30,069	3,100 Added 1.67%	189,100 $1.57 Million
Q2 2019 Aug 02, 2019	BUY	$7.36 - $11.26 $78,016 - $119,356	10,600 Added 6.04%	186,000 $1.6 Million
Q1 2019 May 10, 2019	BUY	$9.08 - $11.84 $61,744 - $80,512	6,800 Added 4.03%	175,400 $1.88 Million
Q4 2018 Feb 13, 2019	BUY	$6.39 - $16.99 $33,228 - $88,347	5,200 Added 3.18%	168,600 $1.48 Million
Q3 2018 Nov 08, 2018	BUY	$16.52 - $24.82 $94,164 - $141,474	5,700 Added 3.61%	163,400 $2.75 Million
Q2 2018 Aug 09, 2018	SELL	$14.31 - $21.75 $248,994 - $378,450	-17,400 Reduced 9.94%	157,700 $3.31 Million
Q1 2018 May 04, 2018	BUY	$16.09 - $23.07 $500,399 - $717,477	31,100 Added 21.6%	175,100 $2.82 Million
Q4 2017 Feb 07, 2018	BUY	$13.36 - $20.73 $130,928 - $203,154	9,800 Added 7.3%	144,000 $2.73 Million
Q3 2017 Nov 03, 2017	BUY	$8.75 - $14.07 $1.17 Million - $1.89 Million	134,200	134,200 $1.89 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account